kr729.50
9.70%
Stockholm, Nov 05, 10:31 am CET. Market open.
Why the stock moved Why the stock moved Beta
ISIN
SE0007692850
Symbol
CAMX
Sector
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Pharmaceuticals

Camurus Stock News

Neutral
Camurus
●
PRNewsWire
●
4 months ago
Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
PDUFA target action date set to 18 December 2026 LUND, Sweden, July 17, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the US Food and Drug Administration (FDA) has accepted for review the resubmission of the New Drug Application (NDA) for CAM2029, octreotide extended-release injection, for the treatment of patients with acromegaly. The FDA has assigned a Prescription Drug...
Camurus
●
●
4 months ago
Camurus Q2 2026 Earnings Call Transcript available
Show summary
Earnings Call Transcript
Negative
Camurus
●
Reuters
●
5 months ago
Camurus' hormone disorder drug expected to be approved in 2027 after fresh FDA setback
Wall Street has pushed to next year expectations for a U.S. approval for Camurus' ​drug to treat a rare hormonal condition after the health ‌regulator's second refusal on Wednesday.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now
The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today